Pharma / Biotech

Targeted Agents Make Their Mark in AML

Over the past two years, eight novel targeted agents have been added to the treatment arsenal for acute myeloid leukemia (AML), making treatment algorithms a bit more complex than the “7+3” chemotherapy induction regimen that has been around for more than 40 years.

Source link




Related posts

Atherosclerosis: Could there be a best time of day for medication?

Newsemia

SUNFORGETTABLE TOTAL PROTECTION FACE SHIELD (Zinc Oxide, Sunscreen) Lotion [Colorescience, Inc.]

Newsemia

KETOTIFEN FUMARATE Solution [McKesson (Sunmark)]

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy